GlassScriptPhysician profile
Colleen Kelly
NPI 1518995992
$12,448.66
in general payments reported to CMS, 2019-2025
6 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.73 · 2020: $21.81 · 2021: $181 · 2022: $1,900 · 2023: $4,141 · 2024: $6,055 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,600 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,400 · Food and Beverage: $256 · Education: $55.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,600.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,400.00 |
| Food and Beverage | $255.89 |
| Education | $55.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $5,655.00 | 2024 | Omvoh |
| Sebela Pharmaceuticals INC. | $3,900.00 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $2,532.37 | 2021-2024 | Rebyota |
| Janssen Biotech, INC. | $255.89 | 2023-2025 | Stelara, Tremfya |
| Abbvie INC. | $105.40 | 2019-2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Colleen Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.